Deuterated tryptamine derivatives and methods of use
US12240813B2 · kind B2 · utility
0Cited by
54References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Jul 10, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.